| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.19 | 1e-05 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.19 | 2e-05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0007 |